Camlin Fine Sciences 将来の成長

Future 基準チェック /46

Camlin Fine Sciences利益と収益がそれぞれ年間119.5%と13.7%増加すると予測されています。EPS は年間増加すると予想されています。自己資本利益率は 3 年後に14% 119.1%なると予測されています。

主要情報

119.5%

収益成長率

119.12%

EPS成長率

Chemicals 収益成長	19.5%
収益成長率	13.7%
将来の株主資本利益率	13.99%
アナリストカバレッジ	Low
最終更新日	09 Apr 2026

今後の成長に関する最新情報

分析記事 • Nov 17

Camlin Fine Sciences Limited Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next

Camlin Fine Sciences Limited ( NSE:CAMLINFINE ) investors will be delighted, with the company turning in some strong...

Recent updates

分析記事 • Dec 09

The Returns On Capital At Camlin Fine Sciences (NSE:CAMLINFINE) Don't Inspire Confidence

What trends should we look for it we want to identify stocks that can multiply in value over the long term? Amongst...

分析記事 • Dec 09

It's Down 26% But Camlin Fine Sciences Limited (NSE:CAMLINFINE) Could Be Riskier Than It Looks

The Camlin Fine Sciences Limited ( NSE:CAMLINFINE ) share price has fared very poorly over the last month, falling by a...

分析記事 • Sep 30

A Look At The Intrinsic Value Of Camlin Fine Sciences Limited (NSE:CAMLINFINE)

Key Insights Camlin Fine Sciences' estimated fair value is ₹184 based on 2 Stage Free Cash Flow to Equity Current share...

分析記事 • Aug 14

The Price Is Right For Camlin Fine Sciences Limited (NSE:CAMLINFINE) Even After Diving 31%

NSEI:CAMLINFINE 1 Year Share Price vs Fair Value Explore Camlin Fine Sciences's Fair Values from the Community and...

分析記事 • Aug 02

This Is Why Camlin Fine Sciences Limited's (NSE:CAMLINFINE) CEO Compensation Looks Appropriate

Key Insights Camlin Fine Sciences' Annual General Meeting to take place on 8th of August CEO Ashish Dandekar's total...

分析記事 • Jun 26

Revenues Tell The Story For Camlin Fine Sciences Limited (NSE:CAMLINFINE) As Its Stock Soars 49%

Camlin Fine Sciences Limited ( NSE:CAMLINFINE ) shares have continued their recent momentum with a 49% gain in the last...

分析記事 • Jun 16

Is Camlin Fine Sciences (NSE:CAMLINFINE) A Risky Investment?

Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it seems the smart money knows that...

分析記事 • May 31

Investors Shouldn't Be Too Comfortable With Camlin Fine Sciences' (NSE:CAMLINFINE) Earnings

Camlin Fine Sciences Limited's ( NSE:CAMLINFINE ) stock was strong after they recently reported robust earnings...

分析記事 • May 10

There's Reason For Concern Over Camlin Fine Sciences Limited's (NSE:CAMLINFINE) Massive 25% Price Jump

The Camlin Fine Sciences Limited ( NSE:CAMLINFINE ) share price has done very well over the last month, posting an...

分析記事 • Feb 25

The Market Lifts Camlin Fine Sciences Limited (NSE:CAMLINFINE) Shares 29% But It Can Do More

Camlin Fine Sciences Limited ( NSE:CAMLINFINE ) shareholders have had their patience rewarded with a 29% share price...

分析記事 • Feb 11

At ₹141, Is Camlin Fine Sciences Limited (NSE:CAMLINFINE) Worth Looking At Closely?

While Camlin Fine Sciences Limited ( NSE:CAMLINFINE ) might not have the largest market cap around , it saw a...

分析記事 • Jan 21

Investors Could Be Concerned With Camlin Fine Sciences' (NSE:CAMLINFINE) Returns On Capital

If we want to find a stock that could multiply over the long term, what are the underlying trends we should look for...

分析記事 • Nov 27

A Piece Of The Puzzle Missing From Camlin Fine Sciences Limited's (NSE:CAMLINFINE) 26% Share Price Climb

Camlin Fine Sciences Limited ( NSE:CAMLINFINE ) shareholders would be excited to see that the share price has had a...

分析記事 • Oct 19

Camlin Fine Sciences (NSE:CAMLINFINE) Will Be Hoping To Turn Its Returns On Capital Around

Finding a business that has the potential to grow substantially is not easy, but it is possible if we look at a few key...

分析記事 • Mar 29

Camlin Fine Sciences (NSE:CAMLINFINE) Has A Somewhat Strained Balance Sheet

Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...

分析記事 • Mar 29

Positive Sentiment Still Eludes Camlin Fine Sciences Limited (NSE:CAMLINFINE) Following 26% Share Price Slump

Unfortunately for some shareholders, the Camlin Fine Sciences Limited ( NSE:CAMLINFINE ) share price has dived 26% in...

分析記事 • Sep 02

Is There An Opportunity With Camlin Fine Sciences Limited's (NSE:CAMLINFINE) 31% Undervaluation?

Key Insights The projected fair value for Camlin Fine Sciences is ₹251 based on 2 Stage Free Cash Flow to Equity...

分析記事 • Apr 06

Is It Time To Consider Buying Camlin Fine Sciences Limited (NSE:CAMLINFINE)?

Camlin Fine Sciences Limited ( NSE:CAMLINFINE ), might not be a large cap stock, but it saw a double-digit share price...

分析記事 • Feb 19

Rainbows and Unicorns: Camlin Fine Sciences Limited (NSE:CAMLINFINE) Analysts Just Became A Lot More Optimistic

Celebrations may be in order for Camlin Fine Sciences Limited ( NSE:CAMLINFINE ) shareholders, with the analysts...

分析記事 • Nov 17

Camlin Fine Sciences Limited Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next

Camlin Fine Sciences Limited ( NSE:CAMLINFINE ) investors will be delighted, with the company turning in some strong...

分析記事 • Oct 15

Should You Think About Buying Camlin Fine Sciences Limited (NSE:CAMLINFINE) Now?

While Camlin Fine Sciences Limited ( NSE:CAMLINFINE ) might not be the most widely known stock at the moment, it...

分析記事 • Jan 15

Camlin Fine Sciences Limited (NSE:CAMLINFINE) Shares Could Be 32% Below Their Intrinsic Value Estimate

Does the January share price for Camlin Fine Sciences Limited ( NSE:CAMLINFINE ) reflect what it's really worth? Today...

分析記事 • Jan 04

Returns On Capital At Camlin Fine Sciences (NSE:CAMLINFINE) Paint A Concerning Picture

If we want to find a potential multi-bagger, often there are underlying trends that can provide clues. In a perfect...

分析記事 • Nov 30

Why Camlin Fine Sciences Limited (NSE:CAMLINFINE) Could Be Worth Watching

While Camlin Fine Sciences Limited ( NSE:CAMLINFINE ) might not be the most widely known stock at the moment, it...

分析記事 • Oct 05

Investors Could Be Concerned With Camlin Fine Sciences' (NSE:CAMLINFINE) Returns On Capital

To find a multi-bagger stock, what are the underlying trends we should look for in a business? Firstly, we'll want to...

業績と収益の成長予測

NSEI:CAMLINFINE - アナリストの将来予測と過去の財務データ ( )INR Millions
日付	収益	収益	フリー・キャッシュフロー	営業活動によるキャッシュ	平均アナリスト数
3/31/2028	23,822	1,630	1,669	N/A	2
3/31/2027	20,380	927	943	N/A	2
3/31/2026	17,919	4	668	N/A	2
12/31/2025	17,780	-141	N/A	N/A	N/A
9/30/2025	17,517	187	-168	283	N/A
6/30/2025	17,092	825	N/A	N/A	N/A
3/31/2025	16,665	685	-157	267	N/A
12/31/2024	16,540	-2,155	N/A	N/A	N/A
9/30/2024	16,064	-2,231	1,000	1,609	N/A
6/30/2024	15,893	-1,423	N/A	N/A	N/A
3/31/2024	14,539	651	784	1,390	N/A
12/31/2023	16,381	-8	N/A	N/A	N/A
9/30/2023	16,400	350	283	785	N/A
6/30/2023	17,174	674	N/A	N/A	N/A
3/31/2023	16,816	577	-934	509	N/A
12/31/2022	16,441	581	N/A	N/A	N/A
9/30/2022	16,371	628	-1,333	1,007	N/A
6/30/2022	14,650	442	N/A	N/A	N/A
3/31/2022	14,121	650	-683	1,454	N/A
12/31/2021	13,495	598	N/A	N/A	N/A
9/30/2021	12,666	465	-544	1,050	N/A
6/30/2021	12,122	579	N/A	N/A	N/A
3/31/2021	11,871	510	335	1,174	N/A
12/31/2020	11,533	394	N/A	N/A	N/A
9/30/2020	11,293	291	540	1,165	N/A
6/30/2020	10,948	302	N/A	N/A	N/A
3/31/2020	10,491	303	-481	860	N/A
12/31/2019	10,243	349	N/A	N/A	N/A
9/30/2019	9,918	277	N/A	424	N/A
6/30/2019	9,709	221	N/A	N/A	N/A
3/31/2019	8,922	6	N/A	-90	N/A
12/31/2018	8,523	-139	N/A	N/A	N/A
9/30/2018	8,186	-222	N/A	N/A	N/A
6/30/2018	7,634	-277	N/A	N/A	N/A
3/31/2018	7,206	-338	N/A	-154	N/A
12/31/2017	6,403	-367	N/A	N/A	N/A
9/30/2017	5,676	-311	N/A	N/A	N/A
6/30/2017	5,347	-275	N/A	N/A	N/A
3/31/2017	5,339	-128	N/A	-87	N/A
12/31/2016	5,149	98	N/A	N/A	N/A
9/30/2016	5,013	174	N/A	N/A	N/A
6/30/2016	5,063	232	N/A	N/A	N/A
3/31/2016	4,893	358	N/A	716	N/A
12/31/2015	5,083	445	N/A	N/A	N/A
9/30/2015	5,238	463	N/A	N/A	N/A
6/30/2015	5,531	552	N/A	N/A	N/A

アナリストによる今後の成長予測

収入対貯蓄率: CAMLINFINEは今後 3 年間で収益性が向上すると予測されており、これは貯蓄率 ( 6.9% ) よりも高い成長率であると考えられます。

収益対市場: CAMLINFINE今後 3 年間で収益性が向上すると予想されており、これは市場平均を上回る成長と考えられます。

高成長収益: CAMLINFINE今後 3 年以内に収益を上げることが予想されます。

収益対市場: CAMLINFINEの収益 ( 13.7% ) Indian市場 ( 10.8% ) よりも速いペースで成長すると予測されています。

高い収益成長: CAMLINFINEの収益 ( 13.7% ) 20%よりも低い成長が予測されています。

一株当たり利益成長率予想

将来の株主資本利益率

将来のROE: CAMLINFINEの自己資本利益率は、3年後には低くなると予測されています ( 14 %)。

成長企業の発掘

企業分析と財務データの現状

データ	最終更新日（UTC時間）
企業分析	2026/05/22 18:30
終値	2026/05/22 00:00
収益	2025/12/31
年間収益	2025/03/31

データソース

企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。

パッケージ	データ	タイムフレーム	米国ソース例
会社財務	10年	損益計算書キャッシュ・フロー計算書貸借対照表	SECフォーム10-K SECフォーム10-Q
アナリストのコンセンサス予想	+プラス3年	予想財務アナリストの目標株価	アナリストリサーチレポート Blue Matrix
市場価格	30年	株価配当、分割、措置	ICEマーケットデータ SECフォームS-1
所有権	10年	トップ株主インサイダー取引	SECフォーム4 SECフォーム13D
マネジメント	10年	リーダーシップ・チーム取締役会	SECフォーム10-K SECフォームDEF 14A
主な進展	10年	会社からのお知らせ	SECフォーム8-K

* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用^。

特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。

分析モデルとスノーフレーク

本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。

シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。

業界およびセクターの指標

私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。

アナリスト筋

Camlin Fine Sciences Limited 2 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、。アナリストの投稿は一日中更新されます。9

アナリスト	機関
Ankur Periwal	Axis Capital Limited
Abhishek Navalgund	Centrum Broking Limited
Satish Kumar	CGS International

Camlin Fine Sciences 将来の成長

Future 基準チェック /46

主要情報

今後の成長に関する最新情報

Price target decreased by 24% to ₹183

Price target decreased by 25% to ₹200

Price target increased by 21% to ₹233

Camlin Fine Sciences Limited Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next

Price target increased to ₹200

Recent updates

Camlin Fine Sciences Limited to Report Q4, 2026 Results on May 26, 2026

Price target decreased by 24% to ₹183

Camlin Fine Sciences Limited to Report Q3, 2026 Results on Feb 13, 2026

New major risk - Share price stability

Now 37% overvalued

Now 22% overvalued

Now 28% overvalued

The Returns On Capital At Camlin Fine Sciences (NSE:CAMLINFINE) Don't Inspire Confidence

It's Down 26% But Camlin Fine Sciences Limited (NSE:CAMLINFINE) Could Be Riskier Than It Looks

Camlin Fine Sciences Limited (BSE:532834) completed the acquisition of 78.68% stake in Vinpai SAS (ENXTPA:ALVIN) from Cyrille Damany, Philippe Le Ray, Chris Project, Alexandre de Selliers de Moranville, Saffelberg Investments NV, Jean-Marc Loiseau and others.

Now 24% overvalued

Second quarter 2026 earnings released: ₹0.29 loss per share (vs ₹5.98 loss in 2Q 2025)

Camlin Fine Sciences Limited to Report Q2, 2026 Results on Nov 10, 2025

Investor sentiment deteriorates as stock falls 15%

A Look At The Intrinsic Value Of Camlin Fine Sciences Limited (NSE:CAMLINFINE)

Now 22% overvalued

Now 20% overvalued

The Price Is Right For Camlin Fine Sciences Limited (NSE:CAMLINFINE) Even After Diving 31%

Camlin Fine Sciences Limited to Report Q1, 2026 Results on Aug 08, 2025

This Is Why Camlin Fine Sciences Limited's (NSE:CAMLINFINE) CEO Compensation Looks Appropriate

Now 21% undervalued

Full year 2025 earnings: EPS and revenues miss analyst expectations

New major risk - Revenue and earnings growth

Revenues Tell The Story For Camlin Fine Sciences Limited (NSE:CAMLINFINE) As Its Stock Soars 49%

Is Camlin Fine Sciences (NSE:CAMLINFINE) A Risky Investment?

Investors Shouldn't Be Too Comfortable With Camlin Fine Sciences' (NSE:CAMLINFINE) Earnings

Investor sentiment improves as stock rises 24%

Camlin Fine Sciences Limited, Annual General Meeting, Aug 08, 2025

Full year 2025 earnings: EPS and revenues miss analyst expectations

Camlin Fine Sciences Limited to Report Q4, 2025 Results on May 23, 2025

There's Reason For Concern Over Camlin Fine Sciences Limited's (NSE:CAMLINFINE) Massive 25% Price Jump

New major risk - Revenue and earnings growth

Now 41% overvalued after recent price rise

Camlin Fine Sciences Limited Approves the Appointment of Pankaj Pawade as Senior General Manager, Effective on or Before May 20, 2025

New minor risk - Share price stability

Camlin Fine Sciences Limited (BSE:532834) agreed to acquire an unknown minority stake in Vinpai SAS (ENXTPA:ALVIN) from Cyrille Damany, Philippe Le Ray, Chris Project, Alexandre de Selliers de Moranville and others.

The Market Lifts Camlin Fine Sciences Limited (NSE:CAMLINFINE) Shares 29% But It Can Do More

Third quarter 2025 earnings: Revenues exceed analysts expectations while EPS lags behind

Now 24% overvalued after recent price rise

Camlin Fine Sciences Limited Approves Appointment of Abeezar Faizullabhoy as Independent Director

At ₹141, Is Camlin Fine Sciences Limited (NSE:CAMLINFINE) Worth Looking At Closely?

Camlin Fine Sciences Limited to Report Q3, 2025 Results on Feb 14, 2025

Camlin Fine Sciences Limited Announces Cessation of Sutapa Banerjee as Independent Director

Investors Could Be Concerned With Camlin Fine Sciences' (NSE:CAMLINFINE) Returns On Capital

New minor risk - Share price stability

New major risk - Revenue and earnings growth

A Piece Of The Puzzle Missing From Camlin Fine Sciences Limited's (NSE:CAMLINFINE) 26% Share Price Climb

Second quarter 2025 earnings released: ₹5.98 loss per share (vs ₹1.17 loss in 2Q 2024)

Camlin Fine Sciences Limited Appoints Saurabh Upadhyay as General Manager - Food Division Designated as Senior Management Personnel

Camlin Fine Sciences Limited to Report Q2, 2025 Results on Nov 11, 2024

Camlin Fine Sciences (NSE:CAMLINFINE) Will Be Hoping To Turn Its Returns On Capital Around

New major risk - Revenue and earnings growth

First quarter 2025 earnings released: ₹2.03 loss per share (vs ₹0.96 profit in 1Q 2024)

Camlin Fine Sciences Limited to Report Q1, 2025 Results on Aug 12, 2024

Full year 2024 earnings: EPS and revenues miss analyst expectations

New major risk - Revenue and earnings growth

Insufficient new directors

New minor risk - Insider selling

Camlin Fine Sciences Limited, Annual General Meeting, Jul 31, 2024

Full year 2024 earnings released: ₹5.58 loss per share (vs ₹3.45 profit in FY 2023)

Camlin Fine Sciences Limited to Report Q4, 2024 Results on May 20, 2024

Chairman & MD recently sold ₹225m worth of stock

Camlin Fine Sciences (NSE:CAMLINFINE) Has A Somewhat Strained Balance Sheet

Positive Sentiment Still Eludes Camlin Fine Sciences Limited (NSE:CAMLINFINE) Following 26% Share Price Slump

Third quarter 2024 earnings released: ₹0.71 loss per share (vs ₹1.53 profit in 3Q 2023)

Camlin Fine Sciences Limited to Report Q3, 2024 Results on Feb 09, 2024

Camlin Fine Sciences Limited Appoints Nilesh Jadhav as Chief Operating Officer

Second quarter 2024 earnings released: ₹1.17 loss per share (vs ₹0.83 profit in 2Q 2023)

Camlin Fine Sciences Limited to Report Q2, 2024 Results on Nov 06, 2023

Price target decreased by 25% to ₹200